32 DAYS TO COVID-19 HUMAN ANTIBODY
IN 3 MONTHS OUR WORLD WAS FOREVER CHANGED.
We are currently experiencing the greatest pandemic in living memory.
IN 1 MONTH PRELLIS BIOLOGICS CAN ISOLATE A PANDEMIC-STOPPING ANTIBODY BY LEVERAGING THE POWER OF THE HUMAN IMMUNE SYSTEM IN THE LABORATORY.
Prellis is rapidly producing a variety of fully human antibodies to COVID-19 for the purpose of conferring temporary immunity and prophylactic treatment options using Prellis synthetic lymph nodes, effectively externalizing a human’s immune system development.
Antibodies confer protection for up to 3 months after injection, which can be used to protect high-risk / high-value healthcare workers. Antibody therapy can be used for treatment of patients who are already infected to reduce disease severity.
10 WEEKS TO HUMAN TRIALS
Synthetic lymph nodes leverage real human immune responses to rapidly (32 days) produce novel human antibodies for production. The process does not require human infection or massive screening libraries. The surrogate human immune system preselects and produces antibodies that can be immediately tested for therapeutic efficacy and scaled for Phase I/II clinical trial use; thus leveraging existing antibody production technologies.